Log in to save to my catalogue

Aberrant RL2 O-GlcNAc antibody reactivity against serum-IgA1 of patients with colorectal cancer

Aberrant RL2 O-GlcNAc antibody reactivity against serum-IgA1 of patients with colorectal cancer

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2491946063

Aberrant RL2 O-GlcNAc antibody reactivity against serum-IgA1 of patients with colorectal cancer

About this item

Full title

Aberrant RL2 O-GlcNAc antibody reactivity against serum-IgA1 of patients with colorectal cancer

Publisher

New York: Springer US

Journal title

Glycoconjugate journal, 2021-02, Vol.38 (1), p.55-65

Language

English

Formats

Publication information

Publisher

New York: Springer US

More information

Scope and Contents

Contents

O
-GlcNAcylation, a single attachment of
N
-acetylglucosamine (GlcNAc) on serine and threonine residues, plays important roles in normal and pathobiological states of many diseases. Aberrant expression of
O
-GlcNAc modification was found in many types of cancer including colorectal cancer (CRC). This modification mainly occurs in nuc...

Alternative Titles

Full title

Aberrant RL2 O-GlcNAc antibody reactivity against serum-IgA1 of patients with colorectal cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2491946063

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2491946063

Other Identifiers

ISSN

0282-0080

E-ISSN

1573-4986

DOI

10.1007/s10719-021-09978-8

How to access this item